MedPath

Senna

Senna

Approved
Approval ID

7c28ffb8-149f-4a5a-ab98-dfa7b3b0f6ed

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 28, 2025

Manufacturers
FDA

PAI Holdings, LLC dba PAI Pharma

DUNS: 044940096

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sennosides

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0121-4967
Application NumberM007
Product Classification
M
Marketing Category
C200263
G
Generic Name
sennosides
Product Specifications
Route of AdministrationORAL
Effective DateApril 28, 2025
FDA Product Classification

INGREDIENTS (8)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4
Classification: IACT
SENNOSIDESActive
Quantity: 8.8 mg in 5 mL
Code: 3FYP5M0IJX
Classification: ACTIB
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
CITRIC ACID ACETATEInactive
Code: DSO12WL7AU
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Senna - FDA Drug Approval Details